Jon Bloom, MD, CEO and Co-founder of Podimetrics
From a digital health perspective, 2022 was a reset year for many and a serious reality check. We went from sky high growth to the sky is falling, and in 2023 I think this market correction movement will continue forward. To me, the biggest surprise of 2022 was that despite the market tanking, digital health companies continued to truck forward with huge deals. This includes massive acquisitions like Amazon and OneMedical, as well as deals like
Read More
insulin
Prescryptive Health Taps Lilly on First-to-Market Value-Based Program to Stabilize Insulin Pricing
What You Should Know:
- Prescryptive Health, a healthcare technology company on a mission to rewrite the script for the U.S. pharmaceutical market partners with Eli Lilly and Company on a new and first-to-market subscription model to help lower costs for people who pay for their Lilly insulin through their employer-sponsored benefits.
- Through a flat, per-member, per-month subscription fee, employers can offer insulin to their employees with predictable, affordable, and transparent costs.
Read More
PatientsLikeMe Partners with LetsGetChecked to Offer Members Access to Home Testing Solutions
What You Should Know:
- PatientsLikeMe (PLM), the trusted community health network that empowers patients to take charge of their health, announced its partnership with LetsGetChecked, a global healthcare solutions company.
- The partnership will provide PLM’s 1 million members with access to enhanced patient support capabilities for testing. PLM’s expansive patient community can now utilize LetsGetChecked’s suite of offerings directly through the PLM platform and receive a discount on
Read More
Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System
What You Should Know:
- The FDA has cleared Dexcom G7 continuous glucose monitoring (CGM) system in the U.S. for people with all types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution.
- Cleared as an integrated continuous glucose monitoring (iCGM) system, Dexcom G7 will be part of the most connected CGM ecosystem in the world, with real-time connectivity that can drive integrated insulin delivery systems, connect
Read More
How Continuous Glucose Monitoring Can Alleviate Language Barriers in Diabetes Care
As an endocrinologist with 19 years of experience in treating patients with diabetes, one of the most important lessons I’ve learned is that communication is key.
Patients with diabetes live with the heavy burden of making choices and taking action every single day to manage their blood glucose levels. Thankfully, advancements in technology have come incredibly far, giving way to tools like continuous glucose monitors (CGM), automated insulin delivery systems and more. But for
Read More
Virta Health Helps AutoZone Employees Reverse Type 2 Diabetes
What You Should Know:
- Type 2 diabetes reversal leader Virta Health revealed promising one-year outcomes from its partnership with AutoZone, Inc., a retailer and distributor of automotive replacement parts and accessories in the Americas.
- Virta provides virtual, continuous health coaching, medical supervision and personalized nutrition to help patients reverse their metabolic disease, lose weight, + get off medications. At one year, AutoZoners experience long-term blood sugar control
Read More
Medtronic Launches World’s First and Only Infusion Set for Insulin Pumps
What You Should Know:
- Medtronic announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labeled for up to 7-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and typically requires a set change every two to three days.
- The Medtronic Extended infusion set uses advanced materials that help reduce insulin preservative loss and maintain insulin flow and stability to double the wear time of an infusion set. The
Read More
HLTH22: Henry Schein Medical Expands SolutionsHub with Rimidi
What You Should Know:
- Henry Schein Medical today announced the expansion of its Solutions Hub with Rimidi, a SaaS company that brings together remote patient monitoring, patient-reported outcomes, and clinical decision support to help enhance patient care.
- With this partnership, clinics, medical groups, and health systems served by Henry Schein will have access to Rimidi’s cloud-based software platform, which helps deliver an efficient model of care for patients with chronic
Read More
Ascensia Launches Diabetes Management and Analytics Platform in the U.S
What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring (BGM) system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, has launched its online diabetes management and analytics platform GlucoContro.online in the United States.
- Now available in more than 15 countries globally and in the process of further expansion, GlucoContro.online support diabetes management by
Read More
Medical Devices Cleared or Approved by FDA in 2022
The medical device industry is booming and shows no signs of slowing down. In 2022, the FDA (Federal Food and Drug Administration) will clear or approve over 1,000 medical devices. This is great news for patients who stand to benefit from the latest and greatest technology, but it can be tough for hospitals and doctors to keep up with all of the new devices on the market.
Here's a breakdown of some of the most anticipated otc medical devices that have already received FDA approval. Some
Read More
